Renowned molecular diagnostics provider CepheidCPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...

Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. The Food and Drug Administration (FDA) issued emergency authorization Saturday for a novel coronavirus ...

CepheidCPHD, a leading player in the molecular diagnostics space, recently announced the commercial launch of its new test Xpert Bladder Cancer Monitor in Germany along with countries accepting the CE ...

Before O’Malley, Reyna, and Hughes. Appeal from the District Court for the Northern District of California. Summary: Testing for the presence of a bacterium that causes tuberculosis and the primers ...

) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Cepheid as such a stock due to the following factors: ...

UNION CITY, Calif. (AP) — Blood analysis systems developer Abaxis Inc. said Wednesday it will receive $17.25 million from medical test maker Cepheid Inc. as part of a patent litigation settlement.

Feb 15 (Reuters) - Genetic analysis system maker Cepheid Inc. said it acquired Sangtec Molecular Diagnostics from Altana for about $27 million in cash. Cepheid said it expects the acquisition to be ...

(Reuters) - Cepheid Inc said it signed deals with the Bill & Melinda Gates Foundation and three other aid organizations to make its tuberculosis diagnostic kit available at reduced prices in ...

Science, health care and technology conglomerate Danaher Corp.DHR0.99%increase; green up pointing triangle said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. for $53.00 a share, ...